DE602006004363D1 - N-oxide als prodrugs von piperazin- und piperidinderivaten - Google Patents

N-oxide als prodrugs von piperazin- und piperidinderivaten

Info

Publication number
DE602006004363D1
DE602006004363D1 DE602006004363T DE602006004363T DE602006004363D1 DE 602006004363 D1 DE602006004363 D1 DE 602006004363D1 DE 602006004363 T DE602006004363 T DE 602006004363T DE 602006004363 T DE602006004363 T DE 602006004363T DE 602006004363 D1 DE602006004363 D1 DE 602006004363D1
Authority
DE
Germany
Prior art keywords
art
relates
disease
manufacture
disclosed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006004363T
Other languages
English (en)
Inventor
Theodorus S Koopman
Hendrik J Koster
Amsterdam Peter H Van
Roelof W Feenstra
Marinus Verhage
Andrew C Mccreary
Mayke B Hesselink
Scharrenburg Gustaaf J Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Healthcare Products BV
Original Assignee
Solvay Pharmaceuticals BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharmaceuticals BV filed Critical Solvay Pharmaceuticals BV
Publication of DE602006004363D1 publication Critical patent/DE602006004363D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/423—Oxazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/24—Oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DE602006004363T 2005-08-22 2006-08-21 N-oxide als prodrugs von piperazin- und piperidinderivaten Active DE602006004363D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US70982105P 2005-08-22 2005-08-22
EP05107671 2005-08-22
PCT/EP2006/065477 WO2007023141A1 (en) 2005-08-22 2006-08-21 N-oxides as prodrugs of piperazine & piperidine derivatives

Publications (1)

Publication Number Publication Date
DE602006004363D1 true DE602006004363D1 (de) 2009-01-29

Family

ID=39246895

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006004363T Active DE602006004363D1 (de) 2005-08-22 2006-08-21 N-oxide als prodrugs von piperazin- und piperidinderivaten

Country Status (17)

Country Link
EP (1) EP1919883B1 (de)
JP (1) JP2009504799A (de)
KR (1) KR20080046205A (de)
AT (1) ATE417834T1 (de)
AU (1) AU2006283882B2 (de)
CA (1) CA2621158A1 (de)
DE (1) DE602006004363D1 (de)
DK (1) DK1919883T3 (de)
ES (1) ES2318783T3 (de)
HR (1) HRP20090143T3 (de)
IL (1) IL188903A0 (de)
NO (1) NO20081435L (de)
PL (1) PL1919883T3 (de)
PT (1) PT1919883E (de)
RU (1) RU2394821C2 (de)
SI (1) SI1919883T1 (de)
WO (1) WO2007023141A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7423040B2 (en) 2005-02-18 2008-09-09 Irene Eijgendaal Stable crystalline form of bifeprunox mesylate, dosage forms thereof and methods for using same
US7964604B2 (en) 2005-02-18 2011-06-21 Solvay Pharmaceuticals B.V. Bifeprunox mesylate maintenance dose compositions and methods for using the same
US7786126B2 (en) 2006-06-16 2010-08-31 Solvay Pharmaceuticals B.V. Combination preparations comprising SLV308 and a dopamine agonist
MY148457A (en) * 2006-06-16 2013-04-30 Solvay Pharm Bv Combination preparations comprising slv308 and a dopamine agonist
CA2661800A1 (en) 2006-08-31 2008-03-06 Solvay Pharmaceuticals B.V. Bifeprunox doses for treating schizophrenia
WO2008127188A1 (en) * 2007-04-12 2008-10-23 Allbay Ab N-oxide and/or di-n-oxide derivatives of dopamine receptor stabilizers/modulators displaying improved cardiovascular side-effects profiles
AU2009204851A1 (en) * 2008-01-15 2009-07-23 Abbott Healthcare Products B.V. Bifeprunox derivatives
WO2011023796A1 (en) 2009-08-31 2011-03-03 Abbott Healthcare Products B.V. Bifeprunox for treating addiction
EP2787997A4 (de) 2011-12-08 2015-05-27 Ivax Int Gmbh Hydrobromidsalz von pridopidin
JP6177875B2 (ja) 2012-04-04 2017-08-09 テバ・ファーマシューティカルズ・インターナショナル・ゲーエムベーハーＴｅｖａ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｔｅｒｎａｔｉｏｎａｌ ＧｍｂＨ 併用療法のための医薬組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE503170A (de) * 1975-09-02
EP0889889B1 (de) * 1996-03-29 2006-09-20 Duphar International Research B.V Piperazin- und piperidin- derivate
UA71590C2 (en) * 1998-11-13 2004-12-15 Duphar Int Res Piperazine and piperidine derivatives
CA2405971C (en) * 2000-05-12 2010-03-30 Solvay Pharmaceuticals B.V. New piperazine and piperidine compounds
US20050085510A1 (en) * 2002-01-16 2005-04-21 Telefonaktiebolaget Lm Ericsson (Publ) Prucalopride-n-oxide

Also Published As

Publication number Publication date
CA2621158A1 (en) 2007-03-01
AU2006283882A1 (en) 2007-03-01
PL1919883T3 (pl) 2009-06-30
RU2008110945A (ru) 2009-09-27
EP1919883A1 (de) 2008-05-14
ES2318783T3 (es) 2009-05-01
NO20081435L (no) 2008-05-16
HRP20090143T3 (en) 2009-04-30
SI1919883T1 (sl) 2009-04-30
WO2007023141A1 (en) 2007-03-01
PT1919883E (pt) 2009-03-26
AU2006283882B2 (en) 2011-06-23
JP2009504799A (ja) 2009-02-05
IL188903A0 (en) 2008-04-13
KR20080046205A (ko) 2008-05-26
DK1919883T3 (da) 2009-04-14
EP1919883B1 (de) 2008-12-17
RU2394821C2 (ru) 2010-07-20
ATE417834T1 (de) 2009-01-15

Similar Documents

Publication Publication Date Title
ATE417834T1 (de) N-oxide als prodrugs von piperazin- und piperidinderivaten
BRPI0407543A (pt) derivados de piperidina-benzenossulfonamida
ATE493407T1 (de) 3-(heteroaryloxy)-2-alkyl-1- azabicycloalkylderivate als alpha.7-nachr- liganden zur behandlung von zns-erkrankungen
NO20051826L (no) Heterosyklisk substituerte piperaziner for behandling av schizofreni
CO5700748A2 (es) Derivados de 4-(2-fenilsulfanil-fenil)-piperidina como inhibidores de recaptacion de serotonina
NO20060324L (no) [1,8]Naftyridin-2-oner og relaterte forbindelser for behandling av Schizofreni
NO20060768L (no) 1-(2-amino-benzol)-piperazinderivater som glycinopptaks-inhibitorer for behandling av psykoser
ATE358482T1 (de) 1-amido-4-phenyl-4-benzyloxymethyl-piperidin derivative und verwandte verbindungen als neurokinin-1 (nk-1) antagonsisten zur behandlung von erbrechen, depressionen, angstzustände und husten
ES2162257T3 (es) N-aminoalquildibenzofurancarboxamidas como ligandos especificos del subtipo de receptor de la dopamina.
UA85707C2 (ru) Бензоксазины для лечения заболеваний дыхательных путей
CO5640133A2 (es) Derivados de 4-(2-feniloxifenil)-piperidina o 1,2,3,6-tetrahidropiridina como inhibidores de la recaptacion de la serotonina
BRPI0709773B8 (pt) derivados de malonamida, processo de produção do mesmo, medicamento, e seus usos como inibidores de gama-secretase no tratamento do mal de alzheimer
ATE201676T1 (de) N-azacycloalkylalkyldibenzothiophencarboxamide: spezifische liganden für dopaminrezeptorsubtypen
GB0412314D0 (en) Compounds
TW200738656A (en) N-oxides as prodrugs of piperazine and piperidine derivatives
EA200501579A1 (ru) Производные 4-(2-фенилсульфанилфенил)-1,2,3,6-тетрагидропиридина в качестве ингибиторов повторного поглощения серотонина
BRPI0514077A (pt) derivados de benzilóxi como inibidores de maob
UA96756C2 (en) N-oxides of pyridylmethylpiperazine and -piperidine derivatives
DE602006003225D1 (de) Chlorsubstituierte guanidine
DE602006015193D1 (de) 8-alk0xy-4-methyl-3, 4-dihydr0-chinaz0lin-2-yl-amine und ihre verwendung als 5-ht5a-rezeptor-liganden
RU2005130647A (ru) НОВЫЕ ПРОИЗВОДНЫЕ АМИНОПИРИДИНА В КАЧЕСТВЕ АНТАГОНИСТОВ mGIuR5
DE502004010108D1 (de) Carbonylamino-substituierte acyl-phenyl-harnstoffderivate, verfahren zu deren herstellung und deren verwendung
TH91553A (th) N-ออกไซด์ที่เป็นโพรดรักส์ของอนุพันธ์พิเพอราซีนและพิเพอริดีน
TH91553B (th) N-ออกไซด์ที่เป็นโพรดรักส์ของอนุพันธ์พิเพอราซีนและพิเพอริดีน
NO20084851L (no) N-oksider av pyridylmetylpiperazin og -piperindinderivater

Legal Events

Date Code Title Description
8364 No opposition during term of opposition